Burden of extraintestinal manifestations and comorbidities in treated and untreated ulcerative colitis and Crohn’s disease: a Latvian nationwide prescription database study 2014–2019

Alinaghi, F., Tekin, H. G., Burisch, J., Wu, J. J., Thyssen, J. P., Egeberg, A. (2020). Global prevalence and bidirectional association between psoriasis and inflammatory bowel disease: A systematic review and meta-analysis. J. Crohn's Colitis, 14 (3), 351–360.10.1093/ecco-jcc/jjz15231504363 Search in Google Scholar

Ananthakrishnan, A. N. (2015). Epidemiology and risk factors for IBD. Nature Rev. Gastroenterol. Hepatol., 12 (4), 205–217. https://doi.org/10.1038/nrgastro.2015.34.10.1038/nrgastro.2015.3425732745 Search in Google Scholar

Baumgart, D. C., Bernstein, C. N., Abbas, Z., Colombel, J. F., Day, A. S., D'Haens, G., Dotan, I., Goh, K. L., Hibi, T., Kozarek, R. A. et al. (2011). IBD Around the world: Comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010–Inflammatory Bowel Disease Task Force meeting. Inflamm. Bowel Dis., 17 (2), 639–644.10.1002/ibd.2140920725944 Search in Google Scholar

Boehncke, W.-H. (2018). Systemic inflammation and cardiovascular comorbidity in psoriasis patients: Causes and consequences. Front Immunol., 9, 579.10.3389/fimmu.2018.00579589564529675020 Search in Google Scholar

Chapman, T. P., Frias Gomes, C., Louis, E., Colombel, J. F., Satsangi, J. (2020). Withdrawal of 5-aminosalicylates in inflammatory bowel disease. Alim. Pharmacol. Ther., 52 (1), 73–84.10.1111/apt.1577132452591 Search in Google Scholar

Cosnes, J., Gowerrousseau, C., Seksik, P., Cortot, A. (2011). Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology, 140, 1785–1794.10.1053/j.gastro.2011.01.05521530745 Search in Google Scholar

Danese, S., Semeraro, S., Papa, A., Roberto, I., Scaldaferri, F., Fedeli, G., Gasbarrini, G., Gasbarrini, A. (2005). Extraintestinal manifestations in inflammatory bowel disease. World J. Gastroenterol., 11 (46), 7227. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725142/. Search in Google Scholar

Doherty, G., Katsanos, K. H., Burisch, J., Allez, M., Papamichael, K., Stallmach, A., Mao, R., Berset, I. P., Gisbert, J. P., Sebastian, S., Kierkuś, J. (2018). European Crohn’s and Colitis Organisation topical review on treatment withdrawal [‘exit strategies’] in inflammatory bowel disease. J. Crohn's Colitis, 12 (1), 17–31. https://academic.oup.com/ecco-jcc/article/12/1/17/4060442#107604318. Search in Google Scholar

Freeman, K., Ryan, R., Parsons, N., Taylor-Phillips, S., Willis, B. H., Clarke, A. (2021). The incidence and prevalence of inflammatory bowel disease in UK primary care: A retrospective cohort study of the IQVIA Medical Research Database. BMC Gastroenterol., 21 (1), 1–7. https://academic.oup.com/jcag/article/2/Supplement_1/S17/5153302?login=true. Search in Google Scholar

Fu, Y., Lee, C. H., Chi, C. C. (2018). Association of psoriasis with inflammatory bowel disease: A systematic review and meta-analysis. JAMA Dermatology, 154 (12), 1417–1423. DOI: 10.1001/jamadermatol.2018.3631.10.1001/jamadermatol.2018.3631658337030422277 Search in Google Scholar

Gjuladin-Hellon, T., Gordon, M., Iheozor-Ejiofor, Z., Akobeng, A. K. (2019). Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease. Cochrane Database of Systematic Reviews, (6). https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008414.pub3/full. Search in Google Scholar

Harbord, M., Annese, V., Vavricka, S. R., Allez, M., Barreiro-de Acosta, M., Boberg, K. M., Burisch, J., De Vos, M., De Vries, A. M., Dick, A. D., Juillerat, P. (2016). The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J. Crohn's Colitis, 10 (3), 239–254. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957476/. Search in Google Scholar

Hedin, C. R. H., Vavricka, S. R., Stagg, A. J., Schoepfer, A., Raine, T., Puig, L., Pleyer, U., Navarini, A., Van Der Meulen-De Jong, A. E., Maul, J., Katsanos, K. (2019). The pathogenesis of extraintestinal manifestations: Implications for IBD research, diagnosis, and therapy. J. Crohn's Colitis, 13 (5), 541–554.10.1093/ecco-jcc/jjy19130445584 Search in Google Scholar

Kaine, J., Song, X., Kim, G., Hur, P., Palmer, J. B. (2018). Higher incidence rates of comorbidities in patients with psoriatic arthritis compared with the general population using US administrative claims data. J. Manag. Care Spec. Pharm., 24, 1–11. Search in Google Scholar

Kirchgesner, J., Beaugerie, L., Carrat, F., Andersen, N. N., Jess, T., Schwarzinger, M. (2017). Increased risk of acute arterial events in young patients and severely active IBD: A nationwide French cohort study. Gut, 67, 1261–1268.10.1136/gutjnl-2017-31401528647686 Search in Google Scholar

Kosmidou, M., Katsanos, A. H., Katsanos, K. H., Kyritsis, A. P., Tsivgpoulis, G., Christodoulou, D., Giannopoulos, S. (2017). Multiple sclerosis and inflammatory bowel diseases: A systematic review and meta-analysis. J. Neurol., 264, 254–259.10.1007/s00415-016-8340-827878439 Search in Google Scholar

Krustins, E., Pokrotnieks, J. (2014). IBD prevalence in Baltic states or just a guessing game? J. Crohn's Colitis, 8 (8), 902–902.10.1016/j.crohns.2014.01.01524491517 Search in Google Scholar

Lakatos, L., Pandur, T., David, G., Balogh, Z., Kuronya, P., Tollas, A., Laszlo, L. (2003). Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: Results of a 25-year follow-up study. World J. Gastroenterol., 9, 2300–2307.10.3748/wjg.v9.i10.2300465648214562397 Search in Google Scholar

Lin, J.-C., Lin, C.-S., Hsu, C.-W., Lin, C.-L., Kao, C.-H. (2016). Association between Parkinson’s disease and inflammatory bowel disease. Inflamm. Bowel Dis., 22, 1049–1055.10.1097/MIB.000000000000073526919462 Search in Google Scholar

Mahid, S. S., Minor, K. S., Soto, R. E., Hornung, C. A., Galandiuk, S. (2006). Smoking and inflammatory bowel disease: A meta-analysis. Mayo Clin. Proc., 81, 1462–1471.10.4065/81.11.146217120402 Search in Google Scholar

McAuliffe, M. E., Lanes, S., Leach, T., Parikh, A., Faich, G., Porter, J., Holick, C., Esposito, D., Zhao, Y., Fox, I. (2015). Occurrence of adverse events among patients with inflammatory bowel disease in the HealthCore Integrated Research Database. Curr. Med. Res. Opin., 31 (9), 1655–1664. https://www.tandfonline.com/doi/abs/10.1185/03007995.2015.1065242?journalCode=icmo20. Search in Google Scholar

Michalek, I. M., Loring, B., John, S. M. (2017). A systematic review of worldwide epidemiology of psoriasis. J. Eur. Acad. Dermatol. Venereol., 31 (2), 205–212. https://onlinelibrary.wiley.com/doi/10.1111/jdv.13854. Search in Google Scholar

Mirzajanova, I., Purviņa, S., Pokrotnieks, J. (2020). Incidence and prevalence of Crohn’s disease and ulerative colitis (2013–2017) based on the Latvian Nationwide Medicines Reimbursement Database. In: Proc. Latvian Acad. Sci. Section B., 74 (2), 138–143. https://sciendo.com/pdf/10.2478/prolas-2020-0022.10.2478/prolas-2020-0022 Search in Google Scholar

Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I., Panaccione, R., Ghosh, S., Barkema, H. W., Kaplan, G. G. (2012). Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology, 142, 46–54. e42; quiz e30.10.1053/j.gastro.2011.10.00122001864 Search in Google Scholar

Nacionālais veselības dienests (2021). Kompensējamie medikamenti. Normatīvo aktu sistēma [National Health Service. Reimbursable drugs. Laws and regulations]. www.vmnvd.gov.lv Search in Google Scholar

OECD (2021). Health at a Glance 2021: OECD Indicators. OECD Publishing, Paris. https://doi.org/10.1787/ae3016b9-en.10.1787/ae3016b9-en Search in Google Scholar

OECD/European Observatory on Health Systems and Policies (2021). Latvia: Country Health Profile 2021. State of Health in the EU. OECD Publishing, Paris. https://doi.org/10.1787/919f55f0-en.10.1787/919f55f0-en Search in Google Scholar

Papa, A., Scaldaferri, F., Danese, S., Guglielmo, S., Roberto, I., Bonizzi, M., Mocci, G., Felice, C., Ricci, C., Andrisani, G., et al. (2008). Vascular involvement in inflammatory bowel disease: Pathogenesis and clinical aspects. Dig. Dis., 26, 149–155.10.1159/00011677318431065 Search in Google Scholar

Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J. C., Saunders, L. D., Beck, C. A., Feasby, T. E., Ghali, W. A. (2005). Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med. Care, 1130–1139. https://journals.lww.com/lww-medicalcare/Abstract/2005/11000/Coding_Algorithms_for_Defining_Comorbidities_in.10.aspx. Search in Google Scholar

Rogler, G., Singh, A., Kavanaugh, A., Rubin, D. T. (2021). Extraintestinal manifestations of inflammatory bowel disease: Current concepts, treatment, and implications for disease management. Gastroenterology, 161 (4), 1118–1132. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564770/. Search in Google Scholar

Román, A. L. S., Muñoz, F. (2011). Comorbidity in inflammatory bowel disease. World J. Gastroenterol., 17, 2723–2733.10.3748/wjg.v17.i22.2723312226021734780 Search in Google Scholar

Ruel, J., Ruane, D., Mehandru, S., Gower-Rousseau, C., Colombel, J. F. (2014). IBD across the age spectrum: Is it the same disease? Nat. Rev. Gastroenterol. Hepatol., 11, 88–98.10.1038/nrgastro.2013.24024345891 Search in Google Scholar

Schüle, S., Rossel, J. B., Frey, D.,Biedermann, L., Scharl, M., Zeitz, J., Freitras-Queiroz, N., Kuntzen, T., Greuter, T. (2017). Widely differing screening and treatment practice for osteoporosis in patients with inflammatory bowel diseases in the Swiss IBD cohort study. Medicine, 96, e6788.10.1097/MD.0000000000006788545969628562531 Search in Google Scholar

Slimību profilakses un kontroles centrs (2019). Smēķēšanas izplatība un sekas Latvijā 2018. gadā. 7. izdevums [Expansion and Consequences of Smoking in Latvia, 2018. 7^th edn.]. Rīga, 2019. 14 pp. (in Latvian). https://www.spkc.gov.lv/lv/zinojumi/tematiskais-zinojums-smekesanas-izplatiba-un-sekas-latvija-2018.gada-7.-izdevums.pdf. Search in Google Scholar

Strober, B., Karki, C., Mason, M., Guo, N., Holmgren, S. H., Greenberg, J. D., Lebwohl, M. (2018). Characterization of disease burden, comorbidities, and treatment use in a large, US-based cohort: Results from the Corrona Psoriasis Registry. J. Amer. Acad. Dermatol., 78 (2), 323–332. https://www.sciencedirect.com/science/article/pii/S019096221732538010.1016/j.jaad.2017.10.01229051036 Search in Google Scholar

Su, C. G., Judge, T. A., Lichtenstein, G. R. (2002). Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol. Clin. North Amer., 31, 307–327.10.1016/S0889-8553(01)00019-X12122740 Search in Google Scholar

Sy, A., Khalidi, N., Dehghan, N., Barra, L., Carette, S., Cuthbertson, D., Hoffman, G. S., Koening, C. L., Langford, C. A., McAlear, C., Moreland, L. (2016). Vasculitis in patients with inflammatory bowel diseases: A study of 32 patients and systematic review of the literature. In: Seminars in Arthritis and Rheumatism, 45 (4), 475–482. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982464/. Search in Google Scholar

Turesson, C. (2016). Comorbidity in rheumatoid arthritis. Swiss Med. Wkly, 146, w14290.10.4414/smw.2016.1429027045333 Search in Google Scholar

Vadstrup, K., Alulis, S., Borsi, A., Jørgensen, T. R., Nielsen, A., Munkholm, P., Qvist, N. (2020). Extraintestinal manifestations and other comorbidities in ulcerative colitis and Crohn Disease: A Danish Nationwide Registry Study 2003–2016. Crohn's Colitis 360, 2 (3), DOI: 10.1093/crocol/otaa070. https://academic.oup.com/crohnscolitis360/article/2/3/otaa070/5896668?login=true. Search in Google Scholar

Van Limbergen, J., Radford-Smith, G., Satsangi, J. (2014). Advances in IBD genetics. Nat. Rev. Gastroenterol. Hepatol., 11, 372–385.10.1038/nrgastro.2014.2724614343 Search in Google Scholar

Van Onna, M., Boonen, A. (2016). The challenging interplay between rheumatoid arthritis, ageing and comorbidities. BMC Musculoskel. Disord., 17, 184.10.1186/s12891-016-1038-3484536327118031 Search in Google Scholar

Vavricka, S. R., Schoepfer, A., Scharl, M., Lakatos, P. L., Navarini, A., Rogler, G. (2015). Extraintestinal manifestations of inflammatory bowel disease. Inflamm. Bowel Dis., 21 (8), 1982–1992. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511685/. Search in Google Scholar

Wagtmans, M. J., Verspaget, H. W., Lamers, C. B. van Hogezand, R. A. (2001). Gender-related differences in the clinical course of Crohn’s disease. Amer. J. Gastroenterol., 96, 1541–1546.10.1111/j.1572-0241.2001.03755.x11374696 Search in Google Scholar

Yarur, A. J., Deshpande, A. R., Pechman, D. M., Tamariz, L., Abreu, M. T., Sussman, D. A. (2011). Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Amer. J. Gastroenterol., 106, 741–747.10.1038/ajg.2011.6321386828 Search in Google Scholar